# BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

> **NCT07410312** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Northwestern University** · enrollment: 20 (estimated)

## Conditions studied

- Lung Transplant Recipient

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT07410312
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-08
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07410312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07410312, "BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07410312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*